Michael Wagner, Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X about his recent article:
“Balancing promise and proof: regulatory challenges in trials for rare cancers – ESMO Rare Cancers”
Title: Balancing promise and proof: regulatory challenges in trials for rare cancers
Authors: M.J. Wagner
More post from Michael J. Wagner on OncoDaily.
